Prevalence of Intracranial Aneurysm in Hong Kong Chinese
1 other identifier
observational
200
1 country
1
Brief Summary
Intracranial aneurysm (localized dilatation in weakened blood vessel wall) rupture is a catastrophic disease, with half of the victims died and many of the survivors disabled. There is currently no data in the literature for the Chinese population concerning the prevalence, characteristics (location and size) and risk of harboring an unruptured intracranial aneurysm. In this study, the investigators aim to study the population prevalence and characteristics (location and size) of intracranial aneurysm in Hong Kong Chinese, and its cost-effectiveness. The screening is carried out using magnetic resonance angiography (MRA), with a 3-T magnetic resonance system, which is a well-established non-invasive method for intracranial aneurysm detection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 26, 2010
CompletedFirst Posted
Study publicly available on registry
March 2, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedApril 23, 2013
April 1, 2013
3 years
February 26, 2010
April 22, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intracranial aneurysm
Three years
Secondary Outcomes (1)
Other intracranial pathologies
Three years
Study Arms (1)
Hong Kong Chinese
Without a history of known intracranial pathologies.
Eligibility Criteria
Hong Kong Chinese without a history of known intracranial pathologies
You may qualify if:
- Healthy adults aged between 21 and 65 years
You may not qualify if:
- Contraindications to MRI
- History of known intracranial pathologies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Surgery, The Chinese University of Hong Kong
Hong Kong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
George KC Wong
Chinese University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor (Clinical)
Study Record Dates
First Submitted
February 26, 2010
First Posted
March 2, 2010
Study Start
January 1, 2010
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
April 23, 2013
Record last verified: 2013-04